The ATM shelf provides capacity for future capital raises but does not represent an immediate dilutive event. Monitor actual takedown volumes in subsequent filings to gauge dilution and use of proceeds toward the IQHQ loan and debt repayment.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5- T+0 · Nov 9 $55.54entry
- T+1 · 7d ago −0.86%α −0.50% · $55.06
- T+5 · 21h ago −5.85%α −4.16% · $52.29
- T+20 · in 21d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
IIPR filed a prospectus supplement to its existing $500M ATM equity shelf program, updating the mix of securities (common, Series A preferred, Series B preferred) and the aggregate amount remaining available for sale to approximately $336.9M. The filing follows a Q3 2026 earnings beat (AFFO $1.96 vs $1.65 consensus) reported 7 days ago, and proceeds are earmarked for life science investments, IQHQ mezzanine loan funding, debt repayment and working capital. The ATM capacity itself is not a priced offering, so the immediate dilutive impact is contingent on future sales.
Key Financial Metrics
Key Facts
- IIPR filed a 424B5 prospectus supplement updating its $500M ATM equity shelf program for common stock, Series A and Series B preferred stock.
- Approximately $163.1M of the $500M shelf has been sold under prior supplements, leaving $336.9M available for future at-the-market sales.
- The filing amends and replaces the prior prospectus supplement dated February 26, 2025, as previously supplemented.
- Proceeds are intended to fund investments (real estate, life science, joint ventures), the IQHQ Alewife Mezzanine Loan ($134M unfunded as of Sep 30, 2026), repay revolving credit facilities ($87.5M and $100M outstanding), and for working capital.
- Sales agents include BTIG, Piper Sandler, Roth Capital Partners, Stifel, A.G.P./Alliance Global Partners, and Huntington Securities; commissions up to 2.0% of gross sales price.
- The supplement also allows for forward sale agreements on common stock, with potential dilution upon physical settlement.
- As of Nov 6, 2026, IIPR had 27,570,861 common shares outstanding, 5,666,082 Series A preferred shares, and 2,167,500 Series B preferred shares.
- Last reported common stock price on Nov 6, 2026 was $54.83 per share.
Financial Impact
Up to $336.9M in potential future equity/preferred capital raises under the ATM program; no immediate priced offering or dilution.
Risk Factors
- Future ATM sales will dilute existing common and preferred shareholders.
- Forward sale agreements, if physically settled, would increase share count and dilute EPS.
- Proceeds deployed into life science investments carry execution and credit risk.
- The company has a history of frequent ATM usage (6 offering/registration filings in 24 months), which may pressure the stock.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 424B5 Filing (Primary) | 0001104659-26-124205 |
| Document: 0001104659-26-124205-index-headers.html | 0001104659-26-124205 |
| Document: 0001104659-26-124205-index.html | 0001104659-26-124205 |
| Document: 0001104659-26-124205.txt | 0001104659-26-124205 |
Track record
22 reports on IIPR
3 of 5 bullish or bearish reports moved the stock their way by T+20. Best: +18.51% at T+60 after the Jul 21, 2026 report. 3 of 5 went positive at some point.
Filters
- Nov 9, 20267d ago 8-K Neutral 2/10 Entry $55.54 Now $52.29 −5.85% settles Dec 8
- Nov 9, 20267d ago 424B5 Neutral 3/10 Viewing Entry $55.54 Now $52.29 −5.85% settles Dec 8
- Nov 6, 202610d ago 8-K Neutral 2/10 Entry $54.83 Now $52.29 −4.63% settles Dec 7
- Nov 2, 202614d ago 8-K Neutral 5/10 Entry $55.00 Now $52.29 −4.93% settles Dec 2
- Oct 28, 202619d ago Institutional Cluster Neutral 3/10 Entry $52.86 Now $52.29 −1.08% settles Nov 25
- Oct 27, 202620d ago SC 13G/A Neutral 3/10 Entry $52.86 Now $52.29 −1.08% settles Nov 25
- Oct 27, 202620d ago 8-K Neutral 4/10 Entry $52.86 Now $52.29 −1.08% settles Nov 25
- Oct 14, 20264w ago 8-K Neutral 4/10 Entry $53.20 to $52.66 Now $52.29 −1.71% ▼ −1.01% +0.89% vs SPY
- Oct 13, 20265w ago Insider Buy Bullish 6/10 Entry $51.43 to $54.74 Now $52.29 +1.67% ▲ +6.44% +7.71% vs SPY
- Oct 9, 20265w ago 424B5 Neutral 4/10 Entry $51.19 to $55.54 Now $52.29 +2.15% ▲ +8.50% +11.76% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers